Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 3
1977 2
1978 4
1979 5
1980 10
1981 10
1982 16
1983 12
1984 25
1985 17
1986 18
1987 34
1988 29
1989 30
1990 62
1991 46
1992 53
1993 75
1994 91
1995 86
1996 83
1997 111
1998 93
1999 109
2000 147
2001 158
2002 176
2003 223
2004 184
2005 190
2006 193
2007 198
2008 173
2009 195
2010 211
2011 240
2012 262
2013 250
2014 267
2015 337
2016 286
2017 330
2018 386
2019 439
2020 370
2021 384
2022 289
2023 249
2024 117

Text availability

Article attribute

Article type

Publication date

Search Results

6,316 results

Results by year

Filters applied: . Clear all
Page 1
How we treat chronic graft-versus-host disease.
Flowers ME, Martin PJ. Flowers ME, et al. Blood. 2015 Jan 22;125(4):606-15. doi: 10.1182/blood-2014-08-551994. Epub 2014 Nov 14. Blood. 2015. PMID: 25398933 Free PMC article. Review.
Keys to successful collaborative management include early recognition in making the diagnosis of chronic GVHD, comprehensive evaluation at the onset and periodically during the course of the disease, prompt institution of systemic and topical treatment, appropriate monitor …
Keys to successful collaborative management include early recognition in making the diagnosis of chronic GVHD, comprehensive evaluation at t …
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.
Goldsmith SR, Abid MB, Auletta JJ, Bashey A, Beitinjaneh A, Castillo P, Chemaly RF, Chen M, Ciurea S, Dandoy CE, Díaz MÁ, Fuchs E, Ganguly S, Kanakry CG, Kanakry JA, Kim S, Komanduri KV, Krem MM, Lazarus HM, Liu H, Ljungman P, Masiarz R, Mulroney C, Nathan S, Nishihori T, Page KM, Perales MA, Taplitz R, Romee R, Riches M. Goldsmith SR, et al. Blood. 2021 Jun 10;137(23):3291-3305. doi: 10.1182/blood.2020009362. Blood. 2021. PMID: 33657221 Free PMC article. Clinical Trial.
Transfusion-associated graft-versus-host disease.
Sunul H, Erguven N. Sunul H, et al. Transfus Apher Sci. 2013 Oct;49(2):331-3. doi: 10.1016/j.transci.2013.07.001. Epub 2013 Jul 23. Transfus Apher Sci. 2013. PMID: 23890576
Vitiligo following stem-cell transplant.
Totani A, Amin H, Bacchi S, Lewis I. Totani A, et al. Bone Marrow Transplant. 2020 Feb;55(2):332-340. doi: 10.1038/s41409-019-0626-x. Epub 2019 Jul 29. Bone Marrow Transplant. 2020. PMID: 31358916 Review.
The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index.
Pidala JA, Hamilton BK, Martin PJ, Onstad L, Storer BE, Palmer J, Alousi A, Cutler C, Jagasia MH, Chen GL, Arora M, Flowers ME, Lee SJ. Pidala JA, et al. Biol Blood Marrow Transplant. 2019 Dec;25(12):2468-2473. doi: 10.1016/j.bbmt.2019.07.040. Epub 2019 Aug 5. Biol Blood Marrow Transplant. 2019. PMID: 31394265 Free PMC article. Clinical Trial.
We found that changes in the scores for the eyes, joint/fascia, and mouth ulcers from baseline to 6 months were associated with subsequent FFS, but the prognostic accuracy of these changes was not adequate for use in trials. Biomarker studies might help to identify criteri …
We found that changes in the scores for the eyes, joint/fascia, and mouth ulcers from baseline to 6 months were associated with subsequent F …
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.
Wolff D, Radojcic V, Lafyatis R, Cinar R, Rosenstein RK, Cowen EW, Cheng GS, Sheshadri A, Bergeron A, Williams KM, Todd JL, Teshima T, Cuvelier GDE, Holler E, McCurdy SR, Jenq RR, Hanash AM, Jacobsohn D, Santomasso BD, Jain S, Ogawa Y, Steven P, Luo ZK, Dietrich-Ntoukas T, Saban D, Bilic E, Penack O, Griffith LM, Cowden M, Martin PJ, Greinix HT, Sarantopoulos S, Socie G, Blazar BR, Pidala J, Kitko CL, Couriel DR, Cutler C, Schultz KR, Pavletic SZ, Lee SJ, Paczesny S. Wolff D, et al. Transplant Cell Ther. 2021 Oct;27(10):817-835. doi: 10.1016/j.jtct.2021.06.001. Epub 2021 Jun 10. Transplant Cell Ther. 2021. PMID: 34217703 Free PMC article.
Progress in preventing severe morbidity and mortality associated with chronic GVHD is limited by a complex and incompletely understood disease biology and a lack of prognostic biomarkers. Likewise, treatment advances for highly morbid manifestations remain hindered by the …
Progress in preventing severe morbidity and mortality associated with chronic GVHD is limited by a complex and incompletely understood disea …
6,316 results